Skip to content

Clinical trials

Terminated Phase 2/3 Stroke trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2/3 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20101
20111
20121
20132
20181
20192
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Bundang Hospital2
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC2
University of California, Los Angeles2
Hospital Ana Nery1
Hospital Geral Roberto Santos1
Maimonides Medical Center1
Ohio State University1
Ono Pharma USA Inc1
University of California, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke12
Hemiplegia3
Ischemic Stroke3
Brain Injuries, Traumatic2
Cerebrovascular Disorders2
Hypothermia2
Muscle Spasticity2
Atherosclerosis1
Atrial Fibrillation1
Body Temperature Changes1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.